Search Results - Nicholas Butowski
- Showing 1 - 20 results of 74
- Go to Next Page
-
1
-
2
Recent Advances in Therapy for Glioblastoma by Jennifer Clarke, Nicholas Butowski, Susan M. Chang
Published 2010Revisão -
3
Treatment options for recurrent high-grade gliomas by Harjus Birk, Seunggu J. Han, Nicholas Butowski
Published 2016Revisão -
4
A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM] by David R. Gibson, Anh Huan Vo, Hannah Lambing, Prithanjan Bhattacharya, Peggy Tahir, Farid Chehab, Nicholas Butowski
Published 2024Revisão -
5
-
6
-
7
-
8
-
9
Characterization and Management of Dermatologic Adverse Events With the NovoTTF-100A System, a Novel Anti-mitotic Electric Field Device for the Treatment of Recurrent Glioblastoma by Mario E. Lacouture, Mary E. Davis, Grace Elzinga, Nicholas Butowski, David Tran, John L. Villano, Lucianna DiMeglio, Angela M. Davies, Eric T. Wong
Published 2014Artigo -
10
-
11
A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma by Jennifer Clarke, Annette M. Molinaro, Joanna J. Phillips, Nicholas Butowski, Shannon Chang, Arie Perry, J Costello, Annissa DeSilva, Jane Rabbitt, Michael D. Prados
Published 2014Artigo -
12
-
13
-
14
Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143 by Antonio Omuro, David A. Reardon, John H. Sampson, Joachim M. Baehring, Solmaz Sahebjam, Timothy F. Cloughesy, Alexandros-Georgios Chalamandaris, Von Potter, Nicholas Butowski, Michael Lim
Published 2022Artigo -
15
Clinical Practice Experience With NovoTTF-100A™ System for Glioblastoma: The Patient Registry Dataset (PRiDe) by Maciej M. Mrugała, Herbert H. Engelhard, David Tran, Yvonne Kew, Robert Cavaliere, John L. Villano, Daniela A. Bota, Jeremy Rudnick, Ashley Sumrall, Jay‐Jiguang Zhu, Nicholas Butowski
Published 2014Artigo -
16
A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05) by Nicholas Butowski, Susan M. Chang, Larry Junck, Lisa M. DeAngelis, Lauren E. Abrey, Karen Fink, Tim Cloughesy, Kathleen R. Lamborn, Andres Μ. Salazar, Michael D. Prados
Published 2008Artigo -
17
A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma by Kazim Narsinh, Karishma Kumar, Krystof Bankiewicz, Alastair J. Martin, Mitchel S. Berger, Jennifer Clarke, Jennie Taylor, Nancy Ann Oberheim Bush, Annette M. Molinaro, Manish K. Aghi, Nicholas Butowski
Published 2025Artigo -
18
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1 by Michael D. Prados, Kathleen R. Lamborn, Susan M. Chang, Eric Burton, Nicholas Butowski, Mary Malec, A. Kapadia, Jane Rabbitt, Margaretta S. Page, Ann Fedoroff, Dong Xie, Sean K. Kelley
Published 2006Artigo -
19
Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma by Susan M. Chang, Sarah J. Nelson, Scott R. VandenBerg, Soonmee Cha, Michael D. Prados, Nicholas Butowski, Michael McDermott, Andrew T. Parsa, Manish K. Aghi, Jennifer Clarke, Mitchel S. Berger
Published 2009Artigo -
20
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma by Jennie Taylor, Mili Parikh, Joanna J. Phillips, C. David James, Annette M. Molinaro, Nicholas Butowski, Jennifer Clarke, Nancy Ann Oberheim-Bush, Susan M. Chang, Mitchel S. Berger, Michael D. Prados
Published 2018Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Oncology
Cancer research
Chemotherapy
Glioma
Surgery
Radiation therapy
Clinical trial
Cancer
Temozolomide
Biology
Pathology
Gene
Glioblastoma
Phases of clinical research
Clinical endpoint
Confidence interval
Genetics
Gastroenterology
Hazard ratio
Adverse effect
Progression-free survival
Bevacizumab
Meningioma
Biochemistry
Environmental health
Population
Adjuvant
Astrocytoma